v3.26.1
Fair Value of Financial Instruments (Tables)
6 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Valuation of Financial Instruments by Pricing Observability Levels
The following table summarizes the valuation of the Company's financial instruments by pricing observability levels defined in FASB Accounting Standards Codification Topic 820, "Fair Value Measurement" ("ASC 820") as of June 30, 2026:
Counterparty
and Cash
Collateral
(Amounts in thousands)Level ILevel IILevel IIINetting (1)Total
Assets
Financial instruments and other inventory positions owned:
Corporate securities:
Convertible securities$— $147,513 $— $— $147,513 
Fixed income securities— 9,677 — — 9,677 
Municipal securities:
Taxable securities— 26,132 — — 26,132 
Tax-exempt securities— 126,827 — — 126,827 
Short-term securities— 39,095 — — 39,095 
Asset-backed securities
— 133,356 — — 133,356 
U.S. government agency securities— 63,341 — — 63,341 
U.S. government securities6,763 — — — 6,763 
Derivative contracts— 4,894 4,056 (3,570)5,380 
Total financial instruments and other inventory positions owned6,763 550,835 4,056 (3,570)558,084 
Cash equivalents270,026 — — — 270,026 
Investments at fair value (2)90,131 — 195,756 — 285,887 
Total assets$366,920 $550,835 $199,812 $(3,570)$1,113,997 
Liabilities
Financial instruments and other inventory positions sold, but not yet purchased:
Corporate securities:
Equity securities$56,262 $— $— $— $56,262 
Fixed income securities— 2,481 — — 2,481 
U.S. government securities20,177 — — — 20,177 
Derivative contracts— 3,394 4,461 (6,230)1,625 
Total financial instruments and other inventory positions sold, but not yet purchased$76,439 $5,875 $4,461 $(6,230)$80,545 
(1)Represents cash collateral and the impact of netting on a counterparty basis. The Company had no securities posted as collateral to its counterparties.
(2)Includes noncontrolling interests of $195.0 million attributable to unrelated third-party ownership in consolidated alternative asset management funds, of which $154.4 million is classified as Level III.

At June 30, 2026, the Company's Level I investments at fair value included $18.6 million of equity securities subject to contractual sale restrictions, of which $15.8 million will expire in the fourth quarter of 2026 and $2.8 million will expire in the first quarter of 2027.
The following table summarizes the valuation of the Company's financial instruments by pricing observability levels defined in ASC 820 as of December 31, 2025:
Counterparty
and Cash
Collateral
(Amounts in thousands)Level ILevel IILevel IIINetting (1)Total
Assets
Financial instruments and other inventory positions owned:
Corporate securities:
Convertible securities$— $140,306 $— $— $140,306 
Fixed income securities— 2,831 — — 2,831 
Municipal securities:
Taxable securities— 33,021 — — 33,021 
Tax-exempt securities— 125,419 — — 125,419 
Short-term securities— 19,531 — — 19,531 
Asset-backed securities
— 92,472 — — 92,472 
U.S. government agency securities— 82,666 — — 82,666 
U.S. government securities201 — — — 201 
Derivative contracts— 5,744 2,352 (2,273)5,823 
Total financial instruments and other inventory positions owned201 501,990 2,352 (2,273)502,270 
Cash equivalents717,600 — — — 717,600 
Investments at fair value (2)87,507 — 217,966 — 305,473 
Total assets$805,308 $501,990 $220,318 $(2,273)$1,525,343 
Liabilities
Financial instruments and other inventory positions sold, but not yet purchased:
Corporate securities:
Fixed income securities$— $3,300 $— $— $3,300 
U.S. government securities43,403 — — — 43,403 
Derivative contracts— 4,039 6,534 (8,762)1,811 
Total financial instruments and other inventory positions sold, but not yet purchased$43,403 $7,339 $6,534 $(8,762)$48,514 
(1)Represents cash collateral and the impact of netting on a counterparty basis. The Company had no securities posted as collateral to its counterparties.
(2)Includes noncontrolling interests of $216.8 million attributable to unrelated third-party ownership in consolidated alternative asset management funds, of which $171.8 million is classified as Level III.
Changes in Fair Value Associated with Level III Financial Instruments
The following tables summarize the changes in fair value associated with Level III financial instruments held at the beginning or end of the periods presented:
Level III
AssetsLiabilities
(Amounts in thousands)
Derivative ContractsInvestments at
Fair Value
Derivative Contracts
Balance at March 31, 2026$4,488 $212,376 $5,246 
Purchases— 6,062 — 
Sales— (6,959)— 
Settlements(1,086)— (3,589)
Transfers in (1)
— — — 
Transfers out (2)
— (7,349)— 
Total realized and unrealized gains/(losses)
654 (8,374)2,804 
Balance at June 30, 2026$4,056 $195,756 $4,461 
Balance at March 31, 2025$4,356 $166,264 $2,278 
Purchases— 23,001 — 
Sales— — — 
Settlements(1,403)— (1,553)
Transfers in (1)
— — — 
Transfers out (2)
— — — 
Total realized and unrealized gains/(losses)
2,570 (4,063)3,645 
Balance at June 30, 2025$5,523 $185,202 $4,370 
Unrealized gains/(losses) for assets/liabilities held at:
June 30, 2026$2,504 $(12,034)$3,627 
June 30, 2025$2,125 $(4,063)$3,109 
Continued on next page
Level III
AssetsLiabilities
(Amounts in thousands)
Derivative ContractsInvestments at
Fair Value
Derivative Contracts
Balance at December 31, 2025$2,352 $217,966 $6,534 
Purchases— 7,345 — 
Sales— (13,238)— 
Settlements(1,780)— (6,071)
Transfers in (1)
— — — 
Transfers out (2)
— (7,349)— 
Total realized and unrealized gains/(losses)
3,484 (8,968)3,998 
Balance at June 30, 2026$4,056 $195,756 $4,461 
Balance at December 31, 2024$1,819 $176,970 $991 
Purchases— 34,487 — 
Sales— — — 
Settlements(1,330)— (1,385)
Transfers in (1)
— — — 
Transfers out (2)
— (8,182)— 
Total realized and unrealized gains/(losses)
5,034 (18,073)4,764 
Balance at June 30, 2025$5,523 $185,202 $4,370 
Unrealized gains/(losses) for assets/liabilities held at:
June 30, 2026$3,984 $(16,455)$3,546 
June 30, 2025$4,532 $(18,073)$4,016 
(1)Transfers into Level III are primarily due to observable inputs becoming unobservable.
(2)Transfers out of Level III are primarily due to unobservable inputs becoming observable.
Information about Significant Unobservable Inputs used in Fair Value Measurement
The following table summarizes quantitative information about the significant unobservable inputs used in the fair value measurement of the Company's Level III financial instruments as of June 30, 2026:
ValuationWeighted
TechniqueUnobservable InputRangeAverage (1)
Assets
Derivative contractsDiscounted cash flowPremium over the MMD curve in basis points ("bps") (3)
0 - 28 bps
10.8 bps
Investments at fair value (2)
Market approachRevenue multiple (3)
3 - 10 times
7.1 times
EBITDA multiple (3)
10 - 19 times
14.8 times
Equity value as multiple of independent financing value (3)
1 - 2 times
1.8 times
Discounted cash flowDiscount rate (4)
15 - 25%
22.0%
Liabilities
Derivative contracts
Discounted cash flowPremium over the MMD curve in bps (4)
0.7 - 36 bps
16.5 bps
(1)Unobservable inputs were weighted by the relative fair value of the financial instruments.
(2)As of June 30, 2026, the Company had $195.8 million of Level III investments at fair value, of which $62.2 million was valued based on a recent round of independent financing.
(3)There is uncertainty in the determination of fair value. Significant increase/(decrease) in the unobservable input in isolation would have resulted in a significantly higher/(lower) fair value measurement.
(4)There is uncertainty in the determination of fair value. Significant increase/(decrease) in the unobservable input in isolation would have resulted in a significantly lower/(higher) fair value measurement.